How to beat the flu: the latest options as a vaccine shortage looms.
D000081:Acetamides / Q000191:economics / Q000627:therapeutic use; D000547:Amantadine / Q000191:economics / Q000627:therapeutic use; D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use; D002487:Centers for Disease Control and Prevention, U.S.; D018795:Device Approval; D016527:Drug Costs; D006801:Humans; D007252:Influenza Vaccines / Q000191:economics / Q000600:supply & distribution; D007251:Influenza, Human / Q000175:diagnosis / Q000188:drug therapy*; D012299:Rimantadine / Q000191:economics / Q000627:therapeutic use; D012307:Risk Factors; D012794:Sialic Acids / Q000191:economics / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000081:Acetamides; D000998:Antiviral Agents; D007252:Influenza Vaccines; D012794:Sialic Acids; D012299:Rimantadine; D000547:Amantadine